Objective POLE exonuclease domain mutations were recently found to occur in a subset of
endometrial carcinomas and result in defective proof-reading function during DNA replication…

Loss of the tumor suppressor gene AT-rich interactive domain-containing protein 1A (ARID1A)
has been demonstrated in several cancers, but its prognostic role is unknown. We aimed …

We aimed to validate the prognostic association of p16 expression in ovarian high‐grade
serous carcinomas (HGSC) and to explore it in other ovarian carcinoma histotypes. p16 protein …

Randomized controlled trials (RCTs), systematic reviews and meta-analyses have shown
that carbohydrate loading before surgery increases insulin sensitivity, reduces postoperative …

Dedifferentiated/undifferentiated endometrial carcinoma (DDEC/UEC) is an endometrial
cancer characterized by the presence of histologically undifferentiated carcinoma. Genomic …

OBJECTIVE: Case reports suggest that hormonal therapy may be a useful treatment option
for low-grade serous carcinomas (LGSC) but the clinical value remains uncertain. We …

TP53 status is the most important prognostic biomarker in endometrial carcinoma. We asked
the question whether p53 mutated endometrial endometrioid carcinomas grade 3 (EEC3) or …

Our objective was to test whether p53 expression status is associated with survival for
women diagnosed with the most common ovarian carcinoma histotypes (high‐grade serous …

Endometrial serous carcinoma (ESC) is an aggressive neoplasm mainly seen in older
women. The objective of this study was to refine immunohistochemical (IHC) panels for the …

Low-grade serous carcinomas and serous borderline tumors, combined herein and referred
to as low-grade serous tumors, show distinct molecular alterations and clinical behaviors …